193 related articles for article (PubMed ID: 36540090)
41. Immunohistochemical assessment of the diagnostic utility of PD-L1: a preliminary analysis of anti-PD-L1 antibody (SP142) for lymphoproliferative diseases with tumour and non-malignant Hodgkin-Reed-Sternberg (HRS)-like cells.
Sakakibara A; Kohno K; Eladl AE; Klaisuwan T; Ishikawa E; Suzuki Y; Shimada S; Nakaguro M; Shimoyama Y; Takahara T; Kato S; Asano N; Nakamura S; Satou A
Histopathology; 2018 Jun; 72(7):1156-1163. PubMed ID: 29380399
[TBL] [Abstract][Full Text] [Related]
42. Follicular peripheral T-cell lymphoma expands the spectrum of classical Hodgkin lymphoma mimics.
Moroch J; Copie-Bergman C; de Leval L; Plonquet A; Martin-Garcia N; Delfau-Larue MH; Molinier-Frenkel V; Belhadj K; Haioun C; Audouin J; Swerdlow SH; Marafioti T; Gaulard P
Am J Surg Pathol; 2012 Nov; 36(11):1636-46. PubMed ID: 23073322
[TBL] [Abstract][Full Text] [Related]
43. Epstein-Barr virus-positive Hodgkin/Reed-Sternberg-like B cell in non-hodgkin lymphoma: nucleotide sequence of the amplified immunoglobulin heavy-chain variable region gene by the single-cell polymerase chain reaction technique.
Nakamura N; Mori N; Ohshima K; Kuze T; Hashimoto Y; Sasaki Y; Shirakawa A; Sato M; Abe M
Diagn Mol Pathol; 2002 Jun; 11(2):83-9. PubMed ID: 12045711
[TBL] [Abstract][Full Text] [Related]
44. Clinicopathological features of adult T-cell leukemia/lymphoma with HTLV-1-infected Hodgkin and Reed-Sternberg-like cells.
Karube K; Takatori M; Sakihama S; Tsuruta Y; Miyagi T; Morichika K; Kitamura S; Nakada N; Hayashi M; Tomori S; Nakazato I; Ohshiro K; Imaizumi N; Kikuti YY; Nakamura N; Morishima S; Masuzaki H; Fukushima T
Blood Adv; 2021 Jan; 5(1):198-206. PubMed ID: 33570645
[TBL] [Abstract][Full Text] [Related]
45. CD30 expression utilization for the accuracy of classical Hodgkin's lymphoma staging.
Flangea C; Potencz E; Mihăescu R; Anghel A; Gîju S; Motoc M; Dogaru C
Rom J Morphol Embryol; 2006; 47(2):113-7. PubMed ID: 17106517
[TBL] [Abstract][Full Text] [Related]
46. CD30 induces Reed-Sternberg cell-like morphology and chromosomal instability in classic Hodgkin lymphoma cell lines.
Watanabe M; Hatsuse H; Nagao K; Nakashima M; Uchimaru K; Otsu M; Miyazaki K; Horie R
Cancer Sci; 2023 Aug; 114(8):3433-3445. PubMed ID: 37302818
[TBL] [Abstract][Full Text] [Related]
47. Leucocyte-specific protein (LSP1) in malignant lymphoma and Hodgkin's disease.
Marafioti T; Jabri L; Pulford K; Brousset P; Mason DY; Delsol G
Br J Haematol; 2003 Feb; 120(4):671-8. PubMed ID: 12588355
[TBL] [Abstract][Full Text] [Related]
48. Epstein-Barr virus in Reed-Sternberg-like cells in non-Hodgkin's lymphomas.
Khan G; Norton AJ; Slavin G
J Pathol; 1993 Jan; 169(1):9-14. PubMed ID: 8381864
[TBL] [Abstract][Full Text] [Related]
49. Ultrastructural comparison of Hodgkin's and non-Hodgkin's lymphomas.
Peiper SC; Kahn LB
Histopathology; 1982 Jan; 6(1):93-109. PubMed ID: 7056514
[TBL] [Abstract][Full Text] [Related]
50. Glycoproteomic characterization of carriers of the CD15/Lewisx epitope on Hodgkin's Reed-Sternberg cells.
Powlesland AS; Barrio MM; Mordoh J; Hitchen PG; Dell A; Drickamer K; Taylor ME
BMC Biochem; 2011 Mar; 12():13. PubMed ID: 21435201
[TBL] [Abstract][Full Text] [Related]
51. Frequent expression of the B-cell-specific activator protein in Reed-Sternberg cells of classical Hodgkin's disease provides further evidence for its B-cell origin.
Foss HD; Reusch R; Demel G; Lenz G; Anagnostopoulos I; Hummel M; Stein H
Blood; 1999 Nov; 94(9):3108-13. PubMed ID: 10556196
[TBL] [Abstract][Full Text] [Related]
52. Coexpression of CD15 and CD20 by Reed-Sternberg cells in Hodgkin's disease.
Zukerberg LR; Collins AB; Ferry JA; Harris NL
Am J Pathol; 1991 Sep; 139(3):475-83. PubMed ID: 1716042
[TBL] [Abstract][Full Text] [Related]
53. Hodgkin's and non-Hodgkin's lymphoma: spectrum of morphologic and immunophenotypic overlap.
Elgin J; Phillips JG; Reddy VV; Gibbs PO; Listinsky CM
Ann Diagn Pathol; 1999 Oct; 3(5):263-75. PubMed ID: 10556472
[TBL] [Abstract][Full Text] [Related]
54. Hodgkin Reed-Sternberg cells express 15-lipoxygenase-1 and are putative producers of eoxins in vivo: novel insight into the inflammatory features of classical Hodgkin lymphoma.
Claesson HE; Griffiths WJ; Brunnström A; Schain F; Andersson E; Feltenmark S; Johnson HA; Porwit A; Sjöberg J; Björkholm M
FEBS J; 2008 Aug; 275(16):4222-34. PubMed ID: 18647347
[TBL] [Abstract][Full Text] [Related]
55. Microenvironment-related biomarkers and novel targets in classical Hodgkin's lymphoma.
Carlo-Stella C; Santoro A
Biomark Med; 2015; 9(8):807-17. PubMed ID: 26223461
[TBL] [Abstract][Full Text] [Related]
56. Glioma-associated oncogene homologue 3, a hedgehog transcription factor, is highly expressed in Hodgkin and Reed-Sternberg cells of classical Hodgkin lymphoma.
Greaves WO; Kim JE; Singh RR; Drakos E; Kunkalla K; Sánchez-Espiridión B; Garcia JF; Medeiros LJ; Vega F
Hum Pathol; 2011 Nov; 42(11):1643-52. PubMed ID: 21531006
[TBL] [Abstract][Full Text] [Related]
57. Nodal involvement by cutaneous CD30-positive T-cell lymphoma mimicking classical Hodgkin lymphoma.
Eberle FC; Song JY; Xi L; Raffeld M; Harris NL; Wilson WH; Pittaluga S; Jaffe ES
Am J Surg Pathol; 2012 May; 36(5):716-25. PubMed ID: 22367293
[TBL] [Abstract][Full Text] [Related]
58. Potential role of hypoxia in early stages of Hodgkin lymphoma pathogenesis.
Wein F; Otto T; Lambertz P; Fandrey J; Hansmann ML; Küppers R
Haematologica; 2015 Oct; 100(10):1320-6. PubMed ID: 26160878
[TBL] [Abstract][Full Text] [Related]
59. Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) with CD30-positive lymphocyte-predominant (LP) cells.
Seliem RM; Ferry JA; Hasserjian RP; Harris NL; Zukerberg LR
J Hematop; 2011 Sep; 4(3):175. PubMed ID: 32288859
[TBL] [Abstract][Full Text] [Related]
60. [Non-Hodgkin's B-cell lymphoma resembling Hodgkin's lymphoma].
Macák J
Cesk Patol; 1994 Dec; 30(4):117-20. PubMed ID: 7859316
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
